Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Menstrual tampon labeling

This article was originally published in The Gray Sheet

Executive Summary

FDA publishes final rule in Oct. 18 Federal Register to apply the term "ultra" absorbency to describe tampons that absorb 15-18 g of fluid, as measured by the syngyna test. The rule is intended to enable consumers to more effectively compare the absorbency of different brands and styles of tampons. The agency also issues a proposed rule changing the standardized menstrual tampon term "junior" to "light," noting that "junior" wrongly implies that the product is intended only for younger women while women of any age with light menstrual flow may seek to use the product

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014015

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel